Uses of Tesmon Injection "Tai Yu"

Tesmon Injection is an injectable drug mainly used in the treatment of certain medical conditions in men. So what is Tesmon Injection and how is it used?

Tesmon Injection is a hormone drug, the drug is prepared in the form of an injectable solution with the main ingredient of Testosterone 25mg/ml.
Among the endogenous male hormones, mainly testosterone, is secreted by the testes and the major metabolite is DHT. The hormone testosterone is responsible for the development of male external and internal sex organs.
The drug helps to maintain secondary sexual characteristics in men such as stimulating hair growth, causing voice breakage, appearance of pleasure. At the same time, this hormone is also responsible for protein assimilation and development of skeletal muscle.
Tesmon Injection is indicated in the following cases:
Congenital or acquired male hypogonadism in men due to the following causes: Orchiectomy Testicular failure Trauma to the hypothalamus-pituitary gland. Delayed puberty in boys Some types of breast cancer in postmenopausal women have bone metastases. Tesmon Injection is contraindicated in the following cases:
People with hypersensitivity to Tesmon Injection drug components. Prostate cancer Prostate cancer. Breast cancer in men Heart failure, kidney failure or severe liver failure. Children who have not yet reached puberty. Aggressive, aggressive state. Use caution when using Tesmon Injection in the following cases:
People with cardiovascular disease, liver failure, kidney failure because it can cause water and electrolyte retention, causing edema. Patients are at risk of hypercalcemia and hypercalciuria. In this case it is necessary to regularly monitor the patient's blood calcium levels.

Tesmon Injection is used by intramuscular route. Dosage of Tesmon Injection should be according to the doctor's instructions, the reference dose is as follows:
Decreased gonads in men: Use a dose of 50mg/time x 2-3 times/week. Delayed puberty in boys: Use a dose of 50mg/week. Treatment of breast cancer in postmenopausal women: Use a dose of 100mg/time x 3 times/week. Precautions when using Tesmon Injection:
Tesmon Injection for doping (+) reactions. Monitor prostate and chest during treatment with Tesmon Injection.

During the use of Tesmon Injection, you may encounter some side effects of the drug:
Side effects at the injection site causing urticaria, inflammation at the injection site. Common side effects of Tesmon Injection include:
Penile erection Changes in sex drive Nitrogen retention, sodium and water retention, swelling. Rapid growth and premature closure of cartilages at the ends of bones (in adolescents) Uncommon side effects of Tesmon Injection include:
Acne Hindering hair Baldness Low sperm count Prostate enlargement Prostate cancer Enlarged breasts in men Loss of menstruation in women. Enlarged heart Heart failure Hypercalcemia, especially in bedridden patient. Poor glucose tolerance Increase low-density lipoprotein (LDL), decrease high-density lipoprotein (HDL), thus increasing the risk of coronary heart disease. Increased hematocrit Increases fibrinolytic activity. Voice changes in women and children. Rare side effects of Tesmon Injection include:
Jaundice, Cholestasis of the liver Carcinoma nearest to get timely support.

Concomitant use of Tesmon Injection and oral anticoagulants will increase the risk of bleeding by increasing the effect of anticoagulants. When initiating Tesmon Injection in a patient taking oral anticoagulants, the dose of the anticoagulant should be reduced to avoid an excessive decrease in serum prothrombin. When patients are taking these drugs concurrently, the physician should regularly monitor the INR and prothrombin time, especially when starting and stopping Tesmon Injection.
Using Tesmon Injection with other antidiabetic drugs may alter the body's sensitivity to insulin or change the patient's ability to control blood sugar. The metabolic effects of Tesmon Injection can reduce blood sugar levels, thereby reducing insulin requirements in patients with diabetes. Therefore, it is necessary to reduce the dose of hypoglycemic agents in diabetic patients if Tesmon Injection is used.
Concomitant use of Tesmon Injection with ACTH or corticosteroids may increase fluid retention and cause coating. Therefore, Tesmon Injection should be used with caution in patients with cardiovascular disease, kidney and/or liver disease.
Long-term use of Tesmon Injection may be resistant to the effects of the following drugs: Suxamethonium and vecuronium.
Tesmon Injection can falsify many test results such as glucose tolerance tests and thyroid function tests.
Hopefully, the above sharing will help users better understand Tesmon Injection as well as the mechanism of action of this drug to bring the best health benefits.